Fig. 1.
Chest computed tomography shows a 6×7 cm, well-enhanced round mass containing multiple calcifications in the left retroperitoneal area.
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Castleman's disease is a rare disorder characterized by benign tumors that may develop in the lymph node tissue throughout the body. Castleman's disease associated with myasthenia gravis is an especially rare disease. Only less than 10 cases have been reported in the world literature. The cause of Castleman's disease is associated with immune mediated reaction, and myasthenia gravis also develops due to an antibody-mediated process. The cause of myasthenia gravis is the immune activity of Castleman's disease, which may be the promoter of the antibody-mediated process. We report here a case of Castleman's disease, which was incidentally found in a patient diagnosed with myasthenia gravis. (Fig. 2) . After the surgery, muscle strength dramatically improved for six months; however, the symptoms recurred and were gradually aggravated. The patient was treated with steroids, and plasmapheresis was performed.
DISCUSSION
Castleman's disease is a rare disorder characterized by be- The patient immediately responded to surgery, but after several months, the symptoms recurred and plasmapheresis was needed. In our case, after complete resection of Castleman's node and thymectomy, muscle strength dramatically improved in the immediate postoperative period, but symptoms recurred after 3 months. According to these results, it is controversial to perform thymectomy for the treatment of Castleman's disease associated with myasthenia gravis. However, at minimum the excision of Castleman's lymph node is necessary.
